| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anna Dietrich-Muszalska, Jolanta Kolińska-Łukaszu. Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma. Psychiatry and clinical neurosciences. vol 72. issue 5. 2018-09-28. PMID:29280533. |
the aim of the present study was to evaluate and compare the effects of a new antipsychotic, aripiprazole (unique due to its mechanism of action), with the effects of selected antipsychotic drugs, such as quetiapine, olanzapine, clozapine, risperidone, and ziprasidone (at the final concentrations corresponding to clinically effective doses used for the treatment of acute episodes of schizophrenia) on lipid peroxidation in human plasma measured by the level of thiobarbituric acid reactive substances (tbars), which is a marker of oxidative stress. |
2018-09-28 |
2023-08-13 |
human |
| Eva Drazanova, Jana Ruda-Kucerova, Lucie Kratka, Katerina Horska, Regina Demlova, Zenon Starcuk, Tomas Kaspare. Poly(I:C) model of schizophrenia in rats induces sex-dependent functional brain changes detected by MRI that are not reversed by aripiprazole treatment. Brain research bulletin. vol 137. 2018-08-31. PMID:29155259. |
poly(i:c) model of schizophrenia in rats induces sex-dependent functional brain changes detected by mri that are not reversed by aripiprazole treatment. |
2018-08-31 |
2023-08-13 |
rat |
| A Cuomo, A Goracci, A Fagiolin. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. Journal of affective disorders. vol 228. 2018-08-27. PMID:29275156. |
aripiprazole is used relatively frequently in women with bipolar disorder or schizophrenia in childbearing years, owing to its efficacy and relatively favorable side effect profile. |
2018-08-27 |
2023-08-13 |
human |
| Shuang-min Ji, An-ning Li, Fang Dong, Liang Li, Tian-yan Zhou, Chuan-yue Wang, Wei L. [Using the cumulative odds Logit model to explore the application of the questionnaire derived from PANSS]. Yao xue xue bao = Acta pharmaceutica Sinica. vol 51. issue 10. 2018-08-21. PMID:29932602. |
currently, aripiprazole, olanzapine and risperidone are three anti-psychiatry agents commonly used in the treatment of schizophrenia. |
2018-08-21 |
2023-08-13 |
Not clear |
| Gerd Lau. Update Psychopharmacotherapy. Medizinische Monatsschrift fur Pharmazeuten. vol 40. issue 1. 2018-08-16. PMID:29952523. |
the introduction of the long acting depot antipsychotics aripiprazole (1 month) and paliperidone (3 months) can be seen as major progress in the treatment of schizophrenia. |
2018-08-16 |
2023-08-13 |
Not clear |
| Steven G Potkin, Robert Risinger, Yangchun Du, Jacqueline Zummo, Anjana Bose, Bernard Silverman, Srdjan Stankovic, Elliot Ehric. Efficacy and safety of aripiprazole lauroxil in schizophrenic patients presenting with severe psychotic symptoms during an acute exacerbation. Schizophrenia research. vol 190. 2018-07-30. PMID:28342578. |
aripiprazole lauroxil (al), a new long-acting injectable antipsychotic, demonstrated safety and efficacy in treating acute exacerbation symptoms of schizophrenia in a 12-week placebo-controlled trial of two doses of al (441mg and 882mg) administered every 4weeks. |
2018-07-30 |
2023-08-13 |
Not clear |
| James E Frampto. Aripiprazole Lauroxil: A Review in Schizophrenia. Drugs. vol 77. issue 18. 2018-07-26. PMID:29177572. |
aripiprazole lauroxil: a review in schizophrenia. |
2018-07-26 |
2023-08-13 |
Not clear |
| Sajeev Kumar P B, Ravi S Pandey, Jagadisha Thirthalli, Siva Kumar P T, Naveen Kumar . A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia. Current neuropharmacology. vol 15. issue 8. 2018-07-16. PMID:28088913. |
a comparative study of short term efficacy of aripiprazole and risperidone in schizophrenia. |
2018-07-16 |
2023-08-13 |
Not clear |
| Bandar E Al-Dhubia. Aripiprazole Nanocrystal Impregnated Buccoadhesive Films for Schizophrenia. Journal of nanoscience and nanotechnology. vol 17. issue 4. 2018-06-19. PMID:29641160. |
aripiprazole nanocrystal impregnated buccoadhesive films for schizophrenia. |
2018-06-19 |
2023-08-13 |
rabbit |
| Bandar E Al-Dhubia. Aripiprazole Nanocrystal Impregnated Buccoadhesive Films for Schizophrenia. Journal of nanoscience and nanotechnology. vol 17. issue 4. 2018-06-19. PMID:29641160. |
aripiprazole is an atypical antipsychotic drug approved worldwide for treatment of acute and long term schizophrenia in adults. |
2018-06-19 |
2023-08-13 |
rabbit |
| Bandar E Al-Dhubia. Aripiprazole Nanocrystal Impregnated Buccoadhesive Films for Schizophrenia. Journal of nanoscience and nanotechnology. vol 17. issue 4. 2018-06-19. PMID:29641160. |
these promising results indicate that the developed nanocrystal loaded buccal films fapz 14 have the potential to provide a faster availability of aripiprazole and the buccoadhesive films offer promising option to patients with schizophrenia especially for geriatric patients. |
2018-06-19 |
2023-08-13 |
rabbit |
| Thomas Beresford, Jennifer Buchanan, Elizabeth Brie Thumm, Chad Emrick, David Weitzenkamp, Patrick J Rona. Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence. Journal of clinical psychopharmacology. vol 37. issue 6. 2018-06-14. PMID:28984746. |
late reduction of cocaine cravings in a randomized, double-blind trial of aripiprazole vs perphenazine in schizophrenia and comorbid cocaine dependence. |
2018-06-14 |
2023-08-13 |
Not clear |
| Takamasa Sakai, Fumiko Ohtsu, Chiyo Mori, Kouichi Tanabe, Nobuyuki Got. Signal of Miscarriage with Aripiprazole: A Disproportionality Analysis of the Japanese Adverse Drug Event Report Database. Drug safety. vol 40. issue 11. 2018-06-04. PMID:28664356. |
one common second-generation antipsychotic given to patients with schizophrenia is aripiprazole. |
2018-06-04 |
2023-08-13 |
Not clear |
| Edith J Liemburg, Frank van Es, Henderikus Knegtering, André Alema. Effects of aripiprazole versus risperidone on brain activation during planning and social-emotional evaluation in schizophrenia: A single-blind randomized exploratory study. Progress in neuro-psychopharmacology & biological psychiatry. vol 79. issue Pt B. 2018-05-29. PMID:28558941. |
effects of aripiprazole versus risperidone on brain activation during planning and social-emotional evaluation in schizophrenia: a single-blind randomized exploratory study. |
2018-05-29 |
2023-08-13 |
Not clear |
| Lyang Huh, Bong Ju Le. [Efficacy of low-Dose Aripiprazole to Treat Clozapine-Associated Tardive Dystonia in a Patient with Schizophrenia]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 28. issue 3. 2018-05-25. PMID:28936820. |
[efficacy of low-dose aripiprazole to treat clozapine-associated tardive dystonia in a patient with schizophrenia]. |
2018-05-25 |
2023-08-13 |
Not clear |
| Arash Raoufinia, Timothy Peters-Strickland, Anna-Greta Nylander, Ross A Baker, Anna Eramo, Na Jin, Patricia Bricmont, Jennifer Repella, Robert D McQuade, Peter Hertel, Frank Larse. Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration. The international journal of neuropsychopharmacology. vol 20. issue 4. 2018-05-18. PMID:28204607. |
two open-label, randomized, parallel-arm studies compared pharmacokinetics, safety, and tolerability of aripiprazole once-monthly 400 mg following deltoid vs gluteal injection in patients with schizophrenia. |
2018-05-18 |
2023-08-13 |
Not clear |
| Hidenobu Ohta, Satoru Inoue, Koichiro Hara, Akihiko Watanab. TSH and PRL, side-effect markers in aripiprazole treatment: adjunctive aripiprazole-induced thyrotropin oversuppression in a young man with schizophrenia. BMJ case reports. vol 2017. 2018-05-09. PMID:28830897. |
tsh and prl, side-effect markers in aripiprazole treatment: adjunctive aripiprazole-induced thyrotropin oversuppression in a young man with schizophrenia. |
2018-05-09 |
2023-08-13 |
Not clear |
| Christoph U Correll, Eva Kohegyi, Cathy Zhao, Ross A Baker, Robert McQuade, Phyllis M Salzman, Raymond Sanchez, Margaretta Nyilas, William Carso. Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study. Journal of the American Academy of Child and Adolescent Psychiatry. vol 56. issue 9. 2018-05-03. PMID:28838583. |
oral aripiprazole as maintenance treatment in adolescent schizophrenia: results from a 52-week, randomized, placebo-controlled withdrawal study. |
2018-05-03 |
2023-08-13 |
Not clear |
| Hanieh Gholampour, Leila Moezi, Hamed Shafarood. Aripiprazole prevents renal ischemia/reperfusion injury in rats, probably through nitric oxide involvement. European journal of pharmacology. vol 813. 2018-05-02. PMID:28734929. |
aripiprazole is an atypical antipsychotic which used for the treatment of schizophrenia and bipolar disorder. |
2018-05-02 |
2023-08-13 |
rat |
| K V Praveen Kumar, P Chiranjeevi, Md Shahid Ala. Aripiprazole-induced transient myopia: A rare entity. Indian journal of ophthalmology. vol 66. issue 1. 2018-04-27. PMID:29283140. |
aripiprazole is a new drug for the treatment of adults with schizophrenia. |
2018-04-27 |
2023-08-13 |
Not clear |